Company Filing History:
Years Active: 2014-2019
Title: Celebrating the Innovations of Curtis Jerome Christensen
Introduction
Curtis Jerome Christensen is an innovative inventor based in Stillwater, MN, renowned for his contributions to the field of biological property testing. With a total of four patents to his name, Christensen focuses on advancing healthcare technology, specifically in the management of blood glucose levels. His groundbreaking inventions reflect a deep understanding of the intersection between science and patient care.
Latest Patents
Christensen's latest patents include a blood glucose management system designed to improve the accuracy and efficiency of testing. The system features a biological property testing device which incorporates a primary surface that extends in a base plane. Additionally, this design includes a first lancet station supported by the base, enhancing user accessibility. Another key feature is the first test strip channel that houses biological test strips, facilitating a streamlined process for blood sample testing.
Another significant invention by Christensen is a lancet device with a flexible cover. This biological test kit is constructed to draw and potentially test biological samples efficiently. It utilizes an array of lancets set in wells within a rigid base, each covered with protective covers that can be easily deformed to allow for safe penetration. These innovative designs showcase his dedication to creating user-friendly and effective medical devices.
Career Highlights
Curtis has been associated with notable companies such as Birch Narrows Development, LLC, and Pops! Diabetes Care, Inc. These affiliations have given him a platform to collaborate with other innovators and further refine his inventions in the healthcare sector. His work plays a significant role in enhancing diabetes management solutions and patient care methodologies.
Collaborations
Throughout his career, Curtis has collaborated with talented individuals, including fellow innovators Daniel W. Davis and Erik Daniel Davis. These partnerships have not only enriched his designs but also expanded the impact of his patented technology, fostering a more innovative approach to biological testing tools.
Conclusion
In summary, Curtis Jerome Christensen stands out as a significant contributor to innovation within the medical technology field. With his impressive portfolio of patents, including a blood glucose management system and an advanced lancet device, he continues to influence the landscape of healthcare solutions. His career exemplifies a commitment to improving patient outcomes through inventive design and collaboration with peers in the industry.